WebApr 10, 2024 · OncoTargets and Therapy is an international, peer-reviewed journal focusing on the molecular diagnosis of and targeted molecular or precision therapy for all types … WebBreast Cancer-Targets and Therapy杂志网站提供期刊影响因子、JCR和中科院分区查询，SCI期刊投稿经验，Impact Factor（IF），官方投稿网址，审稿周期/时间，研究方 …
Did you know?
WebMar 27, 2024 · ISSN: 1179-1314. Breast Cancer: Targets and Therapy is an international, peer reviewed, open access journal focusing on breast cancer, basic and translational research, clinical trials and treatment. The latter includes outcome studies that … WebMar 27, 2024 · Establishment and Validation of a Model for Disease-Free Survival Rate Prediction Using the Combination of microRNA-381 and Clinical Indicators in Patients with Breast Cancer. Shen J, Wang M, Li F, Yan H, Wang R, Zhou J. Breast Cancer: Targets and Therapy 2024, 14:375-389. Published Date: 30 November 2024.
WebBreast Cancer-Targets and Therapy 5年平均影响因子,母语润色,发文量,期刊简介,期刊点评,审稿时间,期刊投稿经验,分区,中科院分区SCI期刊影响因子查询_2024年 (2024年度) 影 … WebApr 10, 2024 · Technology in Cancer Research & Treatment (TCRT) is a peer-reviewed, gold open access journal (featured in SCIE (Web of Science), PMC, and PubMed: …
WebFeb 20, 2024 · Breast Cancer: Targets and Therapy, Volume 14, Issue (2024) See all volumes and issues. Vol 15, 2024 Volume 14, 2024 Vol 13, 2024 Vol 12, 2024 Vol 11, 2024 Vol 10, 2024 Vol 9, 2024 Vol 8, 2016 Vol 7, 2015 Vol 6, 2014 Vol 5, 2013 Vol 3, 2011 Vol 2, 2010 Vol 1, 2009. Issue 2024. Web期刊名称. BREAST CANCER-TARGET/Breast Cancer-Targets and Therapy. ISSN. 1179-1314. 影响指数话题. 影响指数话题. 预警等级. MedSci期刊指数. 1.349 （MedSci实时期刊 …
WebThe focus of this review will be on the development that has occurred within classes of targeted therapies and subsequent impact on breast cancer patient outcomes. We will …
WebApr 10, 2024 · Cancer Biology & Therapy is a high-profile international journal examining all aspects of the molecular basis of cancer, with translational relevance to diagnosis and therapy. The goal is to foster communication and the rapid exchange of information through timely publication of important advances within the field. Topics covered include: ·. stephen downey obituaryWebBreast Cancer: Targets and Therapy has a quicker turnaround time than this. Generally peer review is complete within 3-4 weeks and the editor’s decision within 2-14 days of this. It is therefore very rare to have to wait more than 6 weeks for first editorial decision. pioneer rehabilitation servicesWebBetween 15 and 20 out of every 100 people with breast cancer (between 15 to 20%) have HER2 positive breast cancer. A test on a sample of your cancer will show if it's HER2 positive. An example of treatment that targets this receptor are monoclonal antibodies . stephen downs md alexandria laWebMar 9, 2024 · Breast Cancer: Targets and Therapy, Volume 13, Issue (2024) See all volumes and issues. Vol 15, 2024 Vol 14, 2024 Volume 13, 2024 Vol 12, 2024 Vol 11, 2024 Vol 10, 2024 Vol 9, 2024 Vol 8, 2016 Vol 7, 2015 Vol 6, 2014 Vol 5, 2013 Vol 3, 2011 Vol 2, 2010 Vol 1, 2009. stephen downes glencoreWebApr 5, 2024 · Targeted therapy is a type of cancer treatment that targets the changes in cancer cells that help them grow, divide, and spread. Learn more about targeted therapy drugs that have been approved by the FDA to treat specific types of cancer. ... Targeted therapy approved for breast cancer. Targeted therapy approved for cervical cancer. … pioneer refurbished speakersWebEditorial Panel View Editorial Board. International Journal of Cancer Research & Therapy is an open access peer-reviewed journal publishes latest findings and research in cancer. The Journal is concerned with basic, translational and clinical research, across different disciplines and areas, enhancing insight in understanding, prevention ... stephen doyle 45 from runcorn cheshireWebBreast Cancer: Targets and Therapy is an international, peer reviewed, open access journal focusing on breast cancer, basic and translational research, clinical trials and treatment. The latter includes outcome studies that incorporate preventative and integrated treatment strategies for enhanced survival, and quality of life for cancer patients. pioneer reinsurance brokers